QT
FULC icon

Quantbot Technologies’s Fulcrum Therapeutics FULC Stock Holding History

Quantbot Technologies’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,029
Closed -$87K – 1582
2024
Q2 		$87K Buy
+14,029
New +$106K ﹤0.01% 1152
2023
Q1 		– Sell
-660
Closed -$4.8K – 1722
2022
Q4 		$4.8K Buy
660
+156
+31% +$1.02K ﹤0.01% 1557
2022
Q3 		$4K Buy
+504
New +$3.61K ﹤0.01% 1484
2022
Q2 		– Sell
-4,600
Closed -$108K – 1839
2022
Q1 		$108K Buy
+4,600
New +$65.1K 0.01% 1026

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quantbot Technologies's FULC Position: Q3 2024 in Review

Quantbot Technologies sold out of Fulcrum Therapeutics (FULC) in Q3 2024, closing a stake of 14,029 shares — an estimated $87K sold.

Quantbot Technologies first reported a position in FULC in Q1 2022 and held it in 4 quarters. The position peaked at $108K in Q1 2022. 130 funds tracked by Wall St. Rank hold FULC as of Q3 2024.

  • Quantbot Technologies reported no remaining Fulcrum Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Quantbot Technologies sold 14,029 Fulcrum Therapeutics shares in Q3 2024, an estimated $87K.
  • Quantbot Technologies first reported a position in Fulcrum Therapeutics in Q1 2022 and held it in 4 quarters.
  • Quantbot Technologies's Fulcrum Therapeutics position peaked at $108K in Q1 2022.
  • 130 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2024.

Based on Quantbot Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.